Skip to content
Sino Biopharmaceutical
-
Sanofi acquires global rights to Sino Biopharmaceutical’s Anxu in USD1.53B deal
The agreement includes a USD135 million upfront payment to Sino Biopharmaceutical for worldwide rights, with up to USD1.39 billion in potential milestone payments based on development, regulatory approvals, and sales.